Pneumotox Online
v2.2
  • RSS Feed
  • Contact
  • News
  • Diagnosing DIRD
  • Browse
  • Available on AppStore Available on AppStore

The Drug-Induced Respiratory Disease Website

Philippe Camus, M.D.

Dijon, France

  • Home
  • Browse by »
  • Drugs
  • Patterns

COVID19 (SARS-CoV2) vaccination/vaccine

5

XII.q Pericarditis (see also under XIIc)

1
Last update : 23/07/2021
 
Search
Advanced search
Identify causative drugs
Diagnosing DIRD
1
Drug and radiation history
2
Drug singularity - Correct identification of the drug
3
Consistent timing of exposure v. onset of symptoms
4
Clinical, imaging, BAL, pathological pattern consistent with the specific drug
5
Careful exlusion of another cause
6
Remission of symptoms with removal of drug
7
Recurrence with rechallenge (rarely advisable)
8
Causality assessment
More detailed checklist

Publications

Incessant pericarditis following the second dose of SARS-CoV-2 mRNA vaccine successfully treated with anakinra: a case report.
European heart journal. Case reports 2022 Sep;6;ytac357 2022 Sep
Acute Pericarditis Post mRNA-1273 COVID Vaccine Booster.
Cureus 2022 Feb;14;e22148 2022 Feb
Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study.
Annals of the rheumatic diseases 2021 Oct;80;1330-1338 2021 Oct
Covid-19: Should we be worried about reports of myocarditis and pericarditis after mRNA vaccines?
BMJ (Clinical research ed.) 2021 Jun 24;373;n1635 2021 Jun 24

Powered by

  • ^
  • Contact
  • Cookies
  • About